Our story

Harras Pharma Curarina Arzneimittel GmbH

1977

Acquisition of the Harras Pharmacy in Munich

The company's history begins in 1977 with the acquisition of the Harras Pharmacy. The first products were developed in the pharmacy and registered with the Federal Health Office (now BfArM).

1984

From pharmacy to pharmaceutical company

With the founding of Harras Pharma Curarina Arzneimittel GmbH, the industrial production and distribution of private label products began at home and abroad.

1989

Takeover of the production of Gehrlicher Pharmazeutische Extrakte GmbH in Eurasburg (south of Munich)

The high demand for the predominantly herbal products prompted the company to take over production in-house. This meant that the entire value chain, from development, approval, and production to distribution, was under one roof. Gehrlicher Extrakte was founded in 1964 and already had many years of experience in extract production. Today, Gehrlicher exports a wide variety of specialty extracts as active pharmaceutical ingredients (Drug Master Files) to manufacturers of herbal medicines in 53 countries, far beyond its own requirements. Production is GMP-certified, meaning that the production conditions meet the most modern quality standards for pharmaceuticals.

1995

First production of alcohol-free plant extracts

Gehrlicher Extrakte has particular expertise in the production of alcohol-free herbal specialty extracts. Of particular importance are thyme and ivy extracts, which are still produced in large quantities for children's cough syrups from well-known brands.

2006

Success story Traumaplant® pain cream with comfrey extract

Comfrey extract is brimming with expertise: From plant breeding (patented Trauma Comfrey), optimizing the cultivation method and harvesting to production and clinical testing, it was a long, arduous journey. But the will to succeed and in-depth pharmaceutical knowledge ultimately paid off. This enabled us to develop a pain cream proven effective in numerous clinical studies for use on blunt injuries, bruises, and sprains. Of particular note is the excellent tolerability of the high-dose comfrey extract, which is free of pyrrolizidine alkaloids and other harmful substances, meaning that Traumplant® can even be applied to accompanying open abrasions. Traumaplant® is a top export: Our license partners in the DACH region and international partner companies from Israel, the United Arab Emirates, Peru, Central America, the USA, and Canada value its outstanding quality and effectiveness – made in Germany.

2010

Patenting of Hintonia extract as an antidiabetic

The Hintonia plant is traditionally used in Mexico as a tea for medicinal purposes. In 2010, Gehrlicher Extrakte successfully patented the Hintonia dry extract in Europe. In Germany, Hintonia is marketed under the brand name Sucontral® D for dietary management of diabetes. Sucontral® D has been successfully marketed in the USA since 2015.

2015

Sensicutan® Cream – the cortisone-free alternative for eczema, itching and neurodermatitis

Sensicutan® Cream is also an in-house development based on the active ingredient combination alpha-bisabolol and heparin. The subsequent approval was granted in 2015, paving the way for further export activities. In addition to Germany, Sensicutan® Cream is already approved as a medicinal product in Austria, Switzerland, and Peru, and some are available there. More countries will follow...

2017

Patenting of a special propolis extract against herpes

Under the Herpetino® Cream brand, the medical product made from special propolis extract is exported to Peru, Slovakia, the Czech Republic, and England. Further countries are planned.

2018

Introduction of Glycowohl® in Germany

The product Glycowohl® is licensed to the pharmaceutical company Heilpflanzenwohl GmbH in Berlin. Contract manufacturing is carried out by Gehrlicher Extrakte GmbH in Eurasburg.

2020

Expansion of production for further growth

A new laboratory and tincture production facility is the company's response to the ever-growing demand for medicinal-grade specialty plant extracts. This investment in the future will enable the consistent development of the business with medicinal plant extracts and approved phytotherapeutics worldwide.

2021

Sucontral D becomes Sucontral N

"N" - Stands for your dietary supplement! As part of implementing the legal requirements of the Food Information Regulation (LMIV), we took the opportunity to redesign our packaging. It now appears more modern, clearer, and more consumer-friendly. Best of all: The contents have not changed! The recipe, quality, and quantity remain unchanged.

2022

More space at Harras

By expanding our office space, we are creating optimal conditions for economic growth.

2023

A first-class combination of active ingredients on the road to success

The cortisone-free active principle of the proven combination of natural alpha-bisabolol (Levomenol) and heparin sodium from Harras Pharma has completely convinced our license partner Dr. Wolff and is now also effective in Linola® Duo against itching, eczema, and inflammatory skin diseases such as atopic dermatitis.